4.88
price down icon7.22%   -0.38
after-market Handel nachbörslich: 5.26 0.38 +7.79%
loading

Radiopharm Theranostics Ltd Adr Aktie (RADX) Neueste Nachrichten

pulisher
Nov 02, 2025

Radiopharm (ASX:RAD, Nasdaq:RADX) to Showcase Oncology Pipeline at Deutsche Bank ADR Conference - Kalkine Media

Nov 02, 2025
pulisher
Nov 02, 2025

Radiopharm Theranostics to Present at Deutsche Bank ADR Virtual Investor Conference - TipRanks

Nov 02, 2025
pulisher
Oct 31, 2025

Analysts Are Bullish on These Healthcare Stocks: Bioxcel Therapeutics (BTAI), Perspective Therapeutics (CATX) - The Globe and Mail

Oct 31, 2025
pulisher
Oct 31, 2025

CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - The Globe and Mail

Oct 31, 2025
pulisher
Oct 30, 2025

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 24, 2025

Radiopharm Theranostics Announces November AGM with Key Resolutions - MSN

Oct 24, 2025
pulisher
Oct 21, 2025

Radiopharm Theranostics secures A$35 million in private placement - Investing.com India

Oct 21, 2025
pulisher
Oct 18, 2025

Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Achieve Life Sciences (ACHV) - The Globe and Mail

Oct 18, 2025
pulisher
Oct 12, 2025

Radiopharm Theranostics Accelerates RAD202 Clinical Trial Following Positive Safety Review - MSN

Oct 12, 2025
pulisher
Oct 09, 2025

MasterCraft Boat Holdings Inc (MCFT): What the Financials Tell Us - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Buying Stock In Radiopharm Theranostics Ltd ADR (RADX) A Good Move Today? - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Major Brokerage Firms Issue Research Notes on Surgepays Inc (SURG) - fostersleader.com

Oct 09, 2025
pulisher
Oct 01, 2025

Radiopharm Theranostics Limited: Strategic Advancements and Financial Stability Support Buy Rating - TipRanks

Oct 01, 2025
pulisher
Aug 29, 2025

Analysts Offer Insights on Healthcare Companies: Acrivon Therapeutics, Inc. (ACRV) and Jazz Pharmaceuticals (JAZZ) - The Globe and Mail

Aug 29, 2025
pulisher
Aug 22, 2025

Radiopharm Theranostics Hosts Webinar Series on Radiopharmaceutical Therapies - MSN

Aug 22, 2025
pulisher
Jul 30, 2025

Radiopharm Theranostics: Promising Pipeline and Strategic Advancements Drive Buy Rating - TipRanks

Jul 30, 2025
pulisher
Jul 29, 2025

Radiopharm Theranostics Limited: Promising Clinical Developments and Strategic Growth Potential Drive Buy Rating - TipRanks

Jul 29, 2025
pulisher
Jul 28, 2025

FDA clears Radiopharm’s IND application for Lu177-B7H3 antibody By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

FDA clears Radiopharm’s IND application for Lu177-B7H3 antibody - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Radiopharm Theranostics receives FDA IND approval for Betabart (RV-01) By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

Radiopharm Theranostics receives FDA IND approval for Betabart (RV-01) - Investing.com

Jul 28, 2025
pulisher
Jul 22, 2025

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

Radiopharm Theranostics adds Dr Oliver Sartor to scientific advisory board By Investing.com - Investing.com India

Jul 22, 2025
pulisher
Jul 22, 2025

Radiopharm Theranostics adds Dr Oliver Sartor to scientific advisory board - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Radiopharm Theranostics (NASDAQ:RADX) Now Covered by Brookline Capital Management - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

Radiopharm Theranostics stock initiated with Buy rating at Brookline Capital - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Radiopharm Theranostics stock initiated with Buy rating at Brookline Capital By Investing.com - Investing.com India

Jul 21, 2025
pulisher
Jul 16, 2025

Radiopharm Theranostics receives $4.5 million R&D tax incentive - Investing.com India

Jul 16, 2025
pulisher
Jul 16, 2025

Radiopharm Theranostics receives $4.5 million R&D tax incentive By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 10, 2025

OKYO Pharma (NASDAQ:OKYO) Trading Up 1% – Here’s Why - Defense World

Jul 10, 2025
pulisher
Jun 28, 2025

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and COMPASS Pathways (CMPS) - The Globe and Mail

Jun 28, 2025
pulisher
Jun 24, 2025

Radiopharm signs supply agreement with Cyclotek for prostate cancer drug - Investing.com

Jun 24, 2025
pulisher
Jun 11, 2025

Radiopharm wins FDA fast track for cancer imaging agent By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Radiopharm wins FDA fast track for cancer imaging agent - Investing.com

Jun 11, 2025
pulisher
Jun 04, 2025

Analysts Offer Insights on NA Companies: Tempus AI, Inc. Class A (TEM) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

radiopharm theranostics begins patient dosing in new trial - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

radiopharm theranostics begins patient dosing in new trial By Investing.com - Investing.com India

Jun 04, 2025
pulisher
Jun 02, 2025

radiopharm theranostics shares preclinical data on new cancer therapy By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

radiopharm theranostics shares preclinical data on new cancer therapy - Investing.com

Jun 02, 2025
pulisher
May 19, 2025

Radiopharm secures lutetium-177 supply agreement By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

Radiopharm Theranostics Secures Lutetium-177 Supply Agreement with ITM - TipRanks

May 19, 2025
pulisher
May 19, 2025

Radiopharm secures lutetium-177 supply agreement - Investing.com

May 19, 2025
pulisher
May 13, 2025

Radiopharm advances RAD204 trial with expedited phase By Investing.com - Investing.com India

May 13, 2025
pulisher
May 12, 2025

Radiopharm advances RAD204 trial with expedited phase - Investing.com

May 12, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):